Explore every episode of the podcast The Lancet Respiratory Medicine in conversation with
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Robert Kullberg on empirical antibiotics for Sepsis | 11 Oct 2024 | 00:12:06 | |
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics. Continue this conversation on social! | |||
| Heather Zar on early-life RSV disease and long-term respiratory health | 09 Sep 2024 | 00:19:07 | |
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet. Continue this conversation on social! | |||
| Keith Chappell on a bivalent recombinant vaccine for COVID-19 | 13 Sep 2023 | 00:08:13 | |
Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials. Continue this conversation on social! | |||
| COPD Exacerbation Treatments Around the World: The Lancet Respiratory Medicine: January 2017 | 10 Jan 2017 | 00:09:08 | |
A look at the way COPD exacerbations are treated around the world. Continue this conversation on social! | |||
| Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: January 2017 | 17 Dec 2016 | 00:16:24 | |
Simon Hart provides an overview of the January issue of The Lancet Respiratory Medicine, which focuses on idiopathic pulmonary fibrosis. Continue this conversation on social! | |||
| Bronchiectasis: The Lancet Respiratory Medicine: 21 November 2016 | 21 Nov 2016 | 00:12:50 | |
Melissa McDonnell discusses a new index used to predict mortality and disease outcomes for patients with bronchiectasis. Continue this conversation on social! | |||
| Lung transplantation & preservation: The Lancet Respiratory Medicine: 17 November 2016 | 18 Nov 2016 | 00:07:28 | |
Marcelo Cypel discusses his findings on the use of ex-vivo lung perfusion in preserving transplantable lungs. Continue this conversation on social! | |||
| Sleep apnoea & heart failure: The Lancet Respiratory Medicine: November issue | 25 Oct 2016 | 00:06:16 | |
Christine Eulenburg discusses her study of the SERVE-HF trial. Continue this conversation on social! | |||
| Smoking and mental health: The Lancet Respiratory Medicine: 30 September 2016 | 01 Oct 2016 | 00:06:13 | |
Professor Wayne Hall talks about the challenge of reducing smoking in people with serious mental illness. Continue this conversation on social! | |||
| Cystic fibrosis detection and treatment: The Lancet Respiratory Medicine: August 10, 2016 | 11 Aug 2016 | 00:09:27 | |
Professor Jane Davies discusses current trends in cystic fibrosis detection and treatment. Continue this conversation on social! | |||
| Scleroderma and interstitial lung disease: The Lancet Respiratory Medicine: July 25, 2016 | 26 Jul 2016 | 00:11:12 | |
Donald Tashkin discusses a clinical trial for the treatment of scleroderma-related interstitial lung disease, a rare but devastating condition. Continue this conversation on social! | |||
| COPD care delivery in the USA: The Lancet Respiratory Medicine: May 13, 2016 | 13 May 2016 | 00:10:02 | |
MeiLan Han discusses the highlights of the Commission with Luke Worley. Continue this conversation on social! | |||
| Treating Patients with Persistent Critical Illness: The Lancet Respiratory Medicine: May 4, 2016 | 05 May 2016 | 00:06:13 | |
Dr. Theodore "Jack" Iwashyna discusses the differences between the treatment of patients with acute critical illness and persistent critical illness. Continue this conversation on social! | |||
| James Chalmers on bronchiectasis across Europe | 26 Apr 2023 | 00:11:57 | |
Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry. Continue this conversation on social! | |||
| The Changing Concerns of Pulmonary Disease: The Lancet Respiratory Medicine: April 25, 2016 | 26 Apr 2016 | 00:09:03 | |
Dr. Dirkje Postma of the National Program of Lung Research discusses the changing face of pulmonary disease research. Continue this conversation on social! | |||
| Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: March 31, 2016 | 01 Apr 2016 | 00:07:58 | |
Michael Kreuter discusses a pooled analysis of data on the role of antacid therapy in the progression of idiopathic pulmonary fibrosis. Continue this conversation on social! | |||
| Pulmonary hypertension: The Lancet Respiratory Medicine: March 11, 2016 | 12 Mar 2016 | 00:06:16 | |
Marius Hoeper and Patricia Lobo discuss the global burden of pulmonary hypertension, and options for treatment. Continue this conversation on social! | |||
| Sepsis definitions: The Lancet Respiratory Medicine, February 22, 2016 | 23 Feb 2016 | 00:09:46 | |
Jean-Louis Vincent discusses the changing clinical definition of sepsis. Continue this conversation on social! | |||
| Integrated care pathways: The Lancet Respiratory Medicine : February 2016 | 02 Feb 2016 | 00:05:39 | |
Jean Bousquet discusses integrated care pathways for pulmonary disease. Continue this conversation on social! | |||
| The role of microbiome: The Lancet Respiratory Medicine: January 2016 | 31 Dec 2015 | 00:09:10 | |
Robert Dickson discusses the role of microbiome and the care and treatment of critically ill patients. Continue this conversation on social! | |||
| Air pollution and asthma: The Lancet Respiratory Medicine: Nov 12, 2015 | 12 Nov 2015 | 00:07:45 | |
Ulrike Gehring discusses the link between air pollution and asthma in childhood and adolescence. Continue this conversation on social! | |||
| Eosinophils and asthma: The Lancet Respiratory Medicine: November 2, 2015 | 03 Nov 2015 | 00:13:26 | |
David Price discusses a UK cohort study into the use of blood eosinophil count as a predictor of asthma exacerbations.
Continue this conversation on social! | |||
| Bronchiolitis trial follow-up: The Lancet Respiratory Medicine: Aug 26, 2015 | 27 Aug 2015 | 00:06:45 | |
Håvard Skjerven and Karin Lødrup Carlsen discuss their follow-up study to the bronchiolitis ALL trial, which suggests that giving inhaled epinephrine for acute bronchiolitis in children does not confer benefit, even for those at risk of allergic disease. Continue this conversation on social! | |||
| The UPBEAT study: The Lancet Respiratory Medicine: July 22, 2015 | 23 Jul 2015 | 00:13:40 | |
Timothy Kidd discusses the results of a social network analysis to investigate the spread of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Continue this conversation on social! | |||
| Richard Costello on management of uncontrolled asthma | 21 Mar 2023 | 00:11:38 | |
Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma. Continue this conversation on social! | |||
| COPD exacerbations: The Lancet Respiratory Medicine: July 10, 2015 | 11 Jul 2015 | 00:06:43 | |
Jose Luis Lopez-Campos discusses the heterogeneity of COPD exacerbations and proposes a new approach for treatment. Continue this conversation on social! | |||
| Pleural disease: The Lancet Respiratory Medicine: July 6, 2015 | 06 Jul 2015 | 00:13:27 | |
Nick Maskell and Najib Rahman discuss the pleural disease Series. Continue this conversation on social! | |||
| Life-support: The Lancet Respiratory: June 1, 2015 | 01 Jun 2015 | 00:33:07 | |
Jean-Louis Vincent, Lance Michell, and Pravin Amin discuss country-specific attitudes and approaches to the withdrawing of life-support. Continue this conversation on social! | |||
| GOLD 2007 and GOLD 2011: The Lancet Respiratory Medicine: May 18, 2015 | 18 May 2015 | 00:07:27 | |
Joan Soriano discusses the ability of the GOLD 2007 and 2011 staging systems to predict mortality. Continue this conversation on social! | |||
| Fibrotic interstitial lung diseases: The Lancet Respiratory Medicine: May 12, 2015 | 12 May 2015 | 00:07:27 | |
David Hansell discusses uses of serial CT in drug trials for IPF, and in clinical management of the disease. Continue this conversation on social! | |||
| Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: April 16, 2015 | 17 Apr 2015 | 00:06:30 | |
Michael Durheim discusses surrogate endpoints for trials in IPF. Continue this conversation on social! | |||
| Interleukin 5: The Lancet Respiratory Medicine: March 23, 2015 | 23 Mar 2015 | 00:04:40 | |
Targeting interleukin 5 for eosinophilic asthma – discussion with Jean Bousquet and Richard Lane. Continue this conversation on social! | |||
| 25th issue: The Lancet Respiratory Medicine: March 12, 2015 | 13 Mar 2015 | 00:05:49 | |
Emma Grainger and Richard Lane discuss highlights from the first two years of The Lancet Respiratory Medicine Continue this conversation on social! | |||
| MDR tuberculosis: The Lancet Respiratory Medicine: March 9, 2015 | 10 Mar 2015 | 00:09:15 | |
Ekaterina Kurbatova and Peter Cegielski examine culture conversion as a patient-level predictor of success at end-of-treatment in patients with MDR tuberculosis Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: December 17, 2014 | 17 Dec 2014 | 00:09:19 | |
Michael Matthay and Jennifer Wilson discuss the potential of mesenchymal stem cells for the treatment of ARDS Continue this conversation on social! | |||
| Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer | 06 Mar 2023 | 00:05:51 | |
Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: December 2, 2014 | 04 Dec 2014 | 00:07:15 | |
Adrian Martineau discusses a trial investigating whether vitamin D supplementation reduces the incidence of moderate or severe COPD exacerbations and upper respiratory infections. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: October 31, 2014 | 31 Oct 2014 | 00:14:13 | |
Irene Higginson discusses an RCT on a new palliative care intervention for patients with chronic lung disease. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: October 09, 2014 | 09 Oct 2014 | 00:10:36 | |
Leonardo Fabbri discusses the role of benralizumab for treatment of asthma and COPD. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: August 11, 2014 | 11 Aug 2014 | 00:13:13 | |
Sue Cooper discusses new findings from the SNAP trial, which assesses the effect of nicotine replacement therapy in pregnancy on early childhood development. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: August 04, 2014 | 04 Aug 2014 | 00:07:10 | |
Bianca Schaub discusses a Review of immune mechanisms and the development of childhood asthma. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: June 25, 2014 | 25 Jun 2014 | 00:11:05 | |
Michael Boyle discusses a new therapeutic approach for cystic fibrosis. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: May 13, 2014 | 13 May 2014 | 00:09:52 | |
Brad Drummond discusses a Review on HIV-associated obstructive lung disease. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: April 10, 2014 | 10 Apr 2014 | 00:06:43 | |
Jennifer Verani discusses the effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazilian children. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: April 07, 2014 | 07 Apr 2014 | 00:09:31 | |
James Jackson discusses the BRAIN-ICU study and explains why one in three intensive care survivors develop depression. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: March 24, 2014 | 24 Mar 2014 | 00:13:32 | |
Markus Maeurer discusses the Tuberculosis 2014 Series, which features papers from The Lancet Respiratory Medicine and The Lancet Infectious Diseases. Continue this conversation on social! | |||
| Carol Hodgson on post-discharge outcomes for ECMO patients | 09 Feb 2023 | 00:19:16 | |
Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: February 03, 2014 | 03 Feb 2014 | 00:13:03 | |
Tim Dehnel is joined by Judith Nelson and Elie Azoulay to discuss whether intensive care medics should also be palliative specialists. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: January 27, 2014 | 27 Jan 2014 | 00:09:28 | |
Victor Ortega discusses the effect of rare ADRB2 variants of risk on severe asthma exacerbations in patients receiving treatment with LABAs. Continue this conversation on social! | |||
| The Lancet Respiratory Medicine: December 23, 2013 | 23 Dec 2013 | 00:05:23 | |
Geoff Bellingan discusses the effect of intravenous-beta-1a on lung CD73 expression and on ARDS mortality. Continue this conversation on social! | |||